
==== Front
BMJ OpenBMJ OpenbmjopenbmjopenBMJ Open2044-6055BMJ Publishing Group BMA House, Tavistock Square, London, WC1H 9JR bmjopen-2018-022416corr110.1136/bmjopen-2018-022416corr1Correction1506Correction: The clinician impact and financial cost to the NHS of litigation over pregabalin: a cohort study in English primary care
 2018 30 6 2018 30 6 2018 8 6 bmjopen-2018-022416corr1© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.2018This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/special-featureunlocked
==== Body
Croker R, Smyth D, Walker AJ et al. The clinician impact and financial cost to the NHS of litigation over pregabalin: a cohort study in English primary care. BMJ Open 2018;8:e022416. doi:10.1136/bmjopen-2018-022416.

Figure 5 contains an error. The correct version of Figure 5 is included below.

